Compound of formula (I), wherein Х1 is N or N-O; X4, X5, X6 and X7 are selected from: N , N-O, СH and O, on condition if one therefrom is absent, and the others together create five-member ring and, which value of group R1, R3, R4, R2A, R2B and X2-X3 are disclosed in the claims; pharmaceutically acceptable salts and pharmaceutical compositions on a basis thereof; usage of said compositions and pharmaceutically acceptable salts at the treatment of diseases or disorders caused by muscarine receptor М1. Table: 2